Brief: Johnson & Johnson In Talks To Buy Protagonist Therapeutics - WSJ
10/10/2025 16:17
Oct 10 (Reuters) - JOHNSON & JOHNSON IN TALKS TO BUY PROTAGONIST THERAPEUTICS - WSJ Source text: https://tinyurl.com/yc4a2fjf Further company coverage: JNJ.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagonist Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary